Cargando…

Nutrient drink test: A promising new tool for irritable bowel syndrome diagnosis

BACKGROUND: Irritable bowel syndrome (IBS) is a highly prevalent condition. It is diagnosed on the basis of chronic symptoms after the clinical and/or investigative exclusion of organic diseases that can cause similar symptoms. There is no reproducible non-invasive test for the diagnosis of IBS, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Estremera-Arevalo, Fermin, Barcelo, Marta, Serrano, Blanca, Rey, Enrique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Case Control Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385016/ https://www.ncbi.nlm.nih.gov/pubmed/30809083 http://dx.doi.org/10.3748/wjg.v25.i7.837

Ejemplares similares

Protozoan parasites in irritable bowel syndrome: A case-control study
por: Jadallah, Khaled A, et al.
Publicado: (2017)

Increased colon transit time and faecal load in irritable bowel syndrome
por: Raahave, Dennis, et al.
Publicado: (2021)

Effects of adherence to the Mediterranean diet in children and adolescents with irritable bowel syndrome
por: Al-Biltagi, Mohammed, et al.
Publicado: (2022)

Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?
por: Piscaglia, Anna Chiara, et al.
Publicado: (2016)

Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome
por: Liu, De-Rong, et al.
Publicado: (2018)

Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome
por: Wei, Wei, et al.
Publicado: (2020)

Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome
por: Zhang, Wen-Xue, et al.
Publicado: (2019)

Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease
por: Pedersen, Natalia, et al.
Publicado: (2017)

Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation
por: Mourey, Florian, et al.
Publicado: (2022)

Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs
por: Harvie, Ruth M, et al.
Publicado: (2017)

Exploring the synergistic pharmacological mechanism of Huoxiang Drink against irritable bowel syndrome by integrated data mining and network pharmacology
por: Wang, Ruo-Hui, et al.
Publicado: (2023)

P2Y1R is involved in visceral hypersensitivity in rats with experimental irritable bowel syndrome
por: Wu, Jie, et al.
Publicado: (2017)

Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptoms
por: Serrano-Falcón, Blanca, et al.
Publicado: (2019)

Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial
por: Anderle, Karolina, et al.
Publicado: (2022)

Irritable bowel syndrome diagnosis
por: Tyllis, Nick
Publicado: (2019)

Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report
por: Rey, Enrique, et al.
Publicado: (2017)

Serum neuron-specific enolase: A promising biomarker of silicosis
por: Huang, Hong-Bo, et al.
Publicado: (2021)

Economic burden of irritable bowel syndrome in China
por: Zhang, Fang, et al.
Publicado: (2016)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Promising role of D-amino acids in irritable bowel syndrome
por: Ikeda, Yuka, et al.
Publicado: (2022)

Risk factors for recurrence after bowel resection for Crohn’s disease
por: Chen, Ze-Xian, et al.
Publicado: (2019)

Genetic associations of inflammatory bowel disease in a South Asian population
por: Niriella, Madunil Anuk, et al.
Publicado: (2018)

Stressful life events and psychosocial correlates of pediatric inflammatory bowel disease activity
por: Giannakopoulos, George, et al.
Publicado: (2016)

Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis
por: Matusiewicz, Malgorzata, et al.
Publicado: (2017)

Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study
por: Losurdo, Giuseppe, et al.
Publicado: (2020)

Benefits from Long-Term Treatment in Irritable Bowel Syndrome
por: Evangelista, Stefano
Publicado: (2012)

Self-medication of irritable bowel syndrome and dyspepsia: How appropriate is it?
por: Niknam, Ramin, et al.
Publicado: (2016)

Irritable bowel syndrome evaluation using computed tomography colonography
por: Ohgo, Hideki, et al.
Publicado: (2016)

Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer
por: Wang, Qian-Qian, et al.
Publicado: (2022)

Contemporary diagnosis and management of irritable bowel syndrome /
por: Drossman, Douglas A.
Publicado: (2002)

An expert system for the diagnosis of irritable bowel syndrome
por: SURDEA-BLAGA, TEODORA, et al.
Publicado: (2013)

Update in diagnosis and management of irritable bowel syndrome
por: Hung, Tsung-Hsing, et al.
Publicado: (2023)

Risk factors associated with inflammatory bowel disease: A multicenter case-control study in Brazil
por: Salgado, Valéria Cristina Loureiro, et al.
Publicado: (2020)

Leukocyte immunoglobulin-like receptor B2 overexpression as a promising therapeutic target and noninvasive screening biomarker for colorectal cancer
por: Wang, Qian-Qian, et al.
Publicado: (2023)

Long-term safety and efficacy study of a medical device containing xyloglucan, pea protein reticulated with tannins and xylo-oligosaccharides, in patients with diarrhoea-predominant irritable bowel syndrome
por: de los Rios, Constanza Ciriza, et al.
Publicado: (2021)

Irritable bowel syndrome in adults: Prevalence and risk factors
por: Zeeshan, Muhammad Hamayl, et al.
Publicado: (2022)

Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma
por: Malik, Juliane, et al.
Publicado: (2022)

A protocol for a trial of homeopathic treatment for irritable bowel syndrome
por: Peckham, Emily J, et al.
Publicado: (2012)

Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
por: Fang, Xiu-Cai, et al.
Publicado: (2022)

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
por: Lacy, Brian E
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2vo3brk031jsd7s1au7e8t6r0c